Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Right Prefrontal Autonomic Mapping in Recurrent Pregnancy Loss With Comorbid Anxiety

NCT: NCT06968026 · RECRUITING

NCT IDNCT06968026
StatusRECRUITING
Start Date2025-05-16
Completion2026-05-13

Brief Summary

Recurrent pregnancy loss is often accompanied by substantial anxiety and may also be associated with autonomic imbalance and increased long-term cardiovascular vulnerability. The present proof-of-concept rTMS-ECG parameter-finding trial will examine whether high-intensity, low-frequency, periodic repetitive transcranial magnetic stimulation (rTMS) delivered over the right dorsolateral prefrontal cortex can induce detectable acute cardiac autonomic responses in women with recurrent pregnancy loss and comorbid anxiety disorders. A total of 55 women will be enrolled. During a single experimental session, each participant will undergo a stimulation-intensity sweep protocol with six consecutive stimulation cycles at 100%, 110%, 120%, 130%, 140%, and 150% of resting motor threshold. Each cycle will consist of 40 seconds of 1 Hz stimulation followed by a 20-second rest interval, while electrocardiography will be recorded continuously throughout the procedure. The study will evaluate baseline-corrected heart-rate change, wavelet-derived power near the stimulation-cycle frequency, and the rTMS-induced cardiac coupling index across intensity conditions. The goal is to identify the candidate stimulation intensity that produces the most detectable and physiologically consistent acute cardiac autonomic response for transfer to subsequent NEURO-CARD-rTMS studies.

Frequently Asked Questions

What is Right Prefrontal Autonomic Mapping in Recurrent Pregnancy Loss With Comorbid Anxiety?

Right Prefrontal Autonomic Mapping in Recurrent Pregnancy Loss With Comorbid Anxiety is a clinical trial registered under NCT06968026. Current status: RECRUITING.

What is the status of NCT06968026?

The current status of NCT06968026 (Right Prefrontal Autonomic Mapping in Recurrent Pregnancy Loss With Comorbid Anxiety) is: RECRUITING.

When did Right Prefrontal Autonomic Mapping in Recurrent Pregnancy Loss With Comorbid Anxiety start?

Right Prefrontal Autonomic Mapping in Recurrent Pregnancy Loss With Comorbid Anxiety started on 2025-05-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.